Here are five notes:
1. Mr. Pollard was appointed the positions after Timothy Dick stepped down as senior vice president and chief financial officer.
2. Mr. Pollard joined the company as vice president and corporate controller in April 2015.
3. He previously worked at Novartis Pharmaceuticals, where he served as the head of accounting and reporting for the company’s generic division, Sanoz.
4. Mr. Pollard is a certified public accountant and holds a MBA from Fairleigh Dickinson University in Teaneck, N.J.
5. Akron sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes and rheumatology.
More articles on anesthesia:
U.S. Anesthesia Partners names Dr. Richard Dutton chief quality officer: 5 facts
NorthStar Anesthesia acquires Anesthesia Staffing Consultants: 3 observations
Anesthesia Business Consultants, Stat-App partner: 4 facts
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
